REQUEST A DEMO
Total
USD $0.00
Search more companies

Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) (China)

Main Activities: Alumina and Aluminum Production and Processing | Nonferrous Metal (except Aluminum) Production and Processing
Full name: Wanbangde Pharmaceutical Holding Group Co.,Ltd. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) is an enterprise based in China. Its main office is in Taizhou. The enterprise operates in the Alumina and Aluminum Production and Processing industry. Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) was incorporated on March 31, 1999. It currently has a total number of 1,499 (2024) employees. The latest financial highlights indicate a net sales revenue drop of 5.28% in Q3C2025. Over the same period, its total assets grew by 6.41%. The enterprise’s net profit margin decreased by 3.24% in 2025.

Headquarters
No. 28, Baizhang North Road, Chengdong Street, Wenling City, Taizhou City, Zhejiang Province
Taizhou; Zhejiang; Postal Code: 317500

Contact Details: Purchase the Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) report to view the information.

Website: http://www.wepon.com.cn

Basic Information
Total Employees:
Purchase the Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) report to view the information.
Registered Capital:
Purchase the Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) report to view the information.
Financial Auditors:
Purchase the Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) report to view the information.
Incorporation Date:
March 31, 1999
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
31.62%
Purchase this report to view the information.
8.12%
Purchase this report to view the information.
4.62%
Purchase this report to view the information.
3.67%
Purchase this report to view the information.
2.45%
Subsidiaries
Elite Real Estate, Inc
100%
Hangzhou Guanghua Medical Technology Co., Ltd.
100%
Hangzhou Tianxiang Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Wanbangde Pharmaceutical Holding Group Co.,Ltd. (万邦德医药控股集团股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-5.28%
Total Operating Revenue
-5.21%
Operating Profit
-97.42%
Net Profit/Loss for the Period
-96.46%
Total Assets
6.41%
Total Equity
0.11%
Operating Profit Margin
-3.66%
Net Profit Margin
-3.24%
Return on Equity (ROE)
-1.26%
Debt / Equity
-2652%
Quick Ratio
141.01%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?